Of all the ways cancer changes a person’s financial picture, this one rarely gets discussed: a cancer diagnosis can transform the sale of a life insurance policy from a partially taxable event into one that’s fully exempt from federal income tax. On a six-figure transaction, the difference is often tens of thousands of dollars that stay in the patient’s pocket.
The provision making this possible is Section 101(g) of the Internal Revenue Code. It’s underused, widely misunderstood, and for many cancer patients selling a life insurance policy, it’s the single most valuable thing they’ve never heard of.
This post explains how it works, who qualifies, and what it can mean in real dollars.
The Basic Framework
When you sell a life insurance policy through a standard life settlement — meaning a sale by someone who isn’t seriously ill — the proceeds are taxed in layers under IRS rules:
The portion of proceeds equal to your cost basis (the total premiums you’ve paid into the policy) comes back to you tax-free. The portion above basis up to the policy’s cash surrender value is taxed as ordinary income. Anything beyond that is taxed as long-term capital gain.
It’s not a punishing tax structure, but it’s a real one. On a meaningful settlement, the combined federal tax bite often runs 15 to 30 percent of the gain, depending on your other income.
Section 101(g) provides a fundamentally different result for qualifying transactions: the entire proceeds may be excluded from federal gross income, the same way a life insurance death benefit paid to a beneficiary is excluded. No ordinary income layer. No capital gain layer. The full amount is yours.
This treatment exists because Congress recognized that someone facing terminal or chronic illness selling their policy is essentially accelerating a death benefit they would otherwise have left to their family. Taxing that acceleration would penalize patients for needing the money sooner. Section 101(g) closes that gap.
Who Qualifies: The Two Definitions
To receive Section 101(g) treatment, the seller must meet one of two definitions under federal tax law.
Terminally Ill
A licensed physician must certify that you are “reasonably expected to die within 24 months.” The certification has to come from an actual medical professional based on actual evaluation — not self-reporting, not a checkbox on a form.
For cancer patients, this is the more common qualification path. Many patients with stage III or IV cancers, certain aggressive cancer types, or cancers that have progressed despite treatment will meet this standard. The treating oncologist is typically the right person to make the certification, and a reputable life settlement provider will help coordinate it as part of the transaction process.
It’s worth saying clearly: receiving this certification is not the same as receiving a death sentence. Many patients certified as terminally ill under the 24-month standard live considerably longer than that. The certification reflects a statistical likelihood at a point in time, not a prediction. But the tax treatment, once qualified, is locked in.
Chronically Ill
The second path qualifies you if a licensed healthcare practitioner certifies that you meet either of two conditions:
You are unable to perform at least two activities of daily living — eating, bathing, dressing, transferring, toileting, or continence — without substantial assistance for at least 90 days. Or you require substantial supervision due to severe cognitive impairment.
A care plan must also be in place. Some cancer patients meet this standard during intensive treatment phases or in advanced disease, particularly when treatment side effects are debilitating or when cancer or its treatment has affected cognitive function.
The chronic illness path is less commonly used than the terminal illness path for cancer settlements, but it’s available, and for some patients it’s the right qualification.
What This Looks Like in Real Dollars
Consider a representative example. Imagine a $500,000 universal life policy that has been in force for many years. Total premiums paid into the policy (the cost basis) come to $80,000. The current cash surrender value is $50,000. A buyer offers $250,000 for the policy.
Under standard life settlement tax treatment, the federal tax breakdown looks roughly like this:
The first $80,000 of proceeds (return of basis) is tax-free. There’s no ordinary income layer in this particular example because basis already exceeds surrender value. The remaining $170,000 is taxed as long-term capital gain at federal rates of 15 or 20 percent, depending on your overall income.
Federal tax in this scenario runs roughly $25,000 to $34,000. You walk away with somewhere between $216,000 and $225,000.
Under Section 101(g) treatment, the entire $250,000 may be excluded from federal income tax. The full amount is yours.
That’s $25,000 to $34,000 in additional spendable proceeds on a single transaction, simply because the seller qualified under the right tax provision.
On larger transactions, the differences scale up. A $1 million policy with a $500,000 settlement can produce tax savings of $50,000 to $100,000 or more under Section 101(g) compared to standard treatment.
For cancer patients, this is not a small detail. It can be the single largest financial decision involved in selling the policy.
State Tax Treatment
Most states follow the federal treatment under Section 101(g), meaning state income tax is also avoided on qualifying viatical settlement proceeds. A handful of states have their own rules and definitions that may differ slightly.
This is worth confirming with a tax professional in your specific state before signing anything. The federal treatment is the bigger number for most patients, but state-level treatment can still represent meaningful dollars.
Practical Implications and Common Misconceptions
A few things worth being clear about:
The certification matters, and so does its timing. The physician certification establishing terminal or chronic illness needs to be in place at the time of the transaction. A reputable provider will coordinate this with your treatment team as part of the underwriting and closing process. Don’t assume it happens automatically — confirm it’s being handled.
Not every cancer patient qualifies. A cancer diagnosis alone doesn’t trigger Section 101(g). Early-stage cancers with excellent prognoses, or cancers in long remission, may not meet either the terminal or chronic illness standard. The medical specifics, not just the diagnosis label, drive qualification.
The buyer must be a licensed viatical settlement provider in states that license them. This is one of several reasons it matters whether you work with a properly licensed provider rather than an unlicensed buyer or an out-of-state operator. The tax treatment can be jeopardized if the technical requirements aren’t met.
Reporting still happens. Even when proceeds qualify as tax-free under Section 101(g), the transaction is reported to the IRS on tax forms (typically 1099-LS, and possibly 1099-R). Tax-free doesn’t mean invisible. Keep the forms and bring them to your tax preparer.
This isn’t legal or tax advice for your situation. Section 101(g) qualification depends on specific facts — your medical situation, the certifying physician, the buyer’s licensing status, your state’s rules. Every cancer patient considering a settlement should confirm the expected tax treatment with a CPA or tax attorney before signing a sale agreement.
Other Tax Considerations Worth Knowing About
Section 101(g) is the headline, but a few other tax-adjacent points come up in viatical and life settlement transactions:
Estate tax affects only a small percentage of estates at current federal thresholds, but if your total estate is large enough to potentially face estate tax, the disposition of large life insurance policies has estate planning implications worth discussing with an estate attorney — particularly if the policy is owned by an irrevocable life insurance trust.
Means-tested public benefits (Medicaid, SSI, VA pension, ACA subsidies) have their own rules. Section 101(g) prevents the proceeds from being counted as income for tax purposes, which is helpful for ACA subsidy calculations, but the proceeds are still assets for Medicaid and SSI purposes. This distinction matters and is covered in more detail in our separate post on Medicaid and life settlements.
The interaction with accelerated death benefit (ADB) riders. Many life insurance policies include built-in ADB provisions that pay out a portion of the death benefit early in cases of terminal illness. These ADB payments are also generally tax-free under Section 101(g), often using the same physician certification framework. Some patients use both — taking the ADB amount available under their policy first, then selling what remains.
What This Means If You’re Considering a Settlement
If you’re a cancer patient considering selling a life insurance policy, Section 101(g) should be on your checklist of things to understand and confirm. Specifically:
Ask your treating physician whether they would be able to provide a written certification of terminal illness under the 24-month standard, if your medical situation warrants one. Many oncologists are familiar with this process; for those who aren’t, the certification language is straightforward and a reputable provider can supply a template.
Ask a tax professional to walk through the after-tax outcome of any settlement offer under both standard and Section 101(g) treatment. The difference is often material enough to affect whether the settlement is the right move at all.
Confirm with the provider you’re working with that they’re licensed in your state as a viatical settlement provider, where applicable, and that the transaction will be structured to preserve Section 101(g) eligibility.
Make sure the physician certification is in place before closing, not as an afterthought.
The Bottom Line
For cancer patients selling a life insurance policy, Section 101(g) can be the difference between keeping the full proceeds and giving back tens of thousands of dollars to federal and state taxes. The provision exists specifically to recognize that someone facing serious illness shouldn’t be penalized for accelerating access to a benefit their family would have eventually received anyway.
It’s not automatic, and not every patient qualifies. But for those who do, it’s one of the most consequential tax provisions in the entire Internal Revenue Code applied to their situation. Worth understanding before you make any decision about your policy.
To find out what your policy might be worth — and whether your situation may qualify for Section 101(g) tax-free treatment
A no-cost, no-obligation policy review is available through Settlement Group, a licensed life settlement provider. Call 912-882-0840, email inquiries@settlementgroup.io, or visit settlementgroup.io.
This article provides general information only and is not tax or legal advice. Section 101(g) qualification depends on specific facts about your medical situation, the transaction structure, and applicable state and federal rules. Please consult a CPA or tax attorney about your specific situation before signing any sale agreement.